Long-Term Safety, Tolerability and Efficacy of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus: IGNITE

被引：0
|
作者：
Kawano, Hiromichi
Kashiwagi, Atsunori
Kazuta, Kenichi
Yoshida, Satoshi
Ueyama, Eiji
Utsuno, Atsushi
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2422-PO
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [1] Long-Term Efficacy and Safety of Ipragliflozin plus Insulin in Japanese Patients with Type 2 Diabetes (IOLITE)
    Ishihara, Hisamitsu
    Yamaguchi, Susumu
    Nakao, Ikko
    Okitsu, Akira
    Asahina, Seitaro
    DIABETES, 2017, 66 : A335 - A335
  • [2] Efficacy and Safety of Long-Term Administration of Dapagliflozin for Japanese Patients with Type 2 Diabetes Mellitus
    Yamazaki, Masahiro
    Sakai, Ryosuke
    Okamura, Takuro
    Fukui, Michiaki
    DIABETES, 2018, 67
  • [3] Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Kaku, Kohei
    Kondo, Kazuoki
    Maruyama, Nobuko
    Otsuka, Makiko
    Kawaguchi, Yutaka
    Iijima, Hiroaki
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 812 - 820
  • [4] Long-term efficacy and tolerability of acarbose treatment in patients with type 2 diabetes mellitus
    Segal, P
    Eliahou, HE
    Petzinna, D
    Neuser, D
    Brückner, A
    Spengler, M
    CLINICAL DRUG INVESTIGATION, 2005, 25 (09) : 589 - 595
  • [5] Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus
    Pesach Segal
    Haskel E. Eliahou
    Dieter Petzinna
    Dieter Neuser
    Andreas Brückner
    Manfred Spengler
    Clinical Drug Investigation, 2005, 25 : 589 - 595
  • [6] Long-term Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus
    Tada, Yuko
    Kanazawa, Ippei
    Notsu, Masakazu
    Tanaka, Ken-ichiro
    Kiyohara, Nobuaki
    Sasaki, Motofumi
    Sugimoto, Toshitsugu
    INTERNAL MEDICINE, 2016, 55 (10) : 1275 - 1278
  • [7] Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus
    Liakos, Aris
    Karagiannis, Thomas
    Bekiari, Eleni
    Boura, Panagiota
    Tsapas, Apostolos
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (02) : 61 - 67
  • [8] Long-term safety, tolerability, and efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes
    Odawara M.
    Kadowaki T.
    Tajima N.
    Nishii M.
    Taniguchi T.
    Ferreira J.C.A.
    Diabetology International, 2011, 2 (2) : 94 - 105
  • [9] Efficacy and safety of adding ipragliflozin to insulin in Japanese patients with type 1 diabetes mellitus: a retrospective study
    Shimoda, Masashi
    Mashiko, Akiko
    Katakura, Yukino
    Sanada, Junpei
    Fushimi, Yoshiro
    Obata, Atsushi
    Kimura, Tomohiko
    Kohara, Kenji
    Tatsumi, Fuminori
    Nakanishi, Shuhei
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    ENDOCRINE JOURNAL, 2021, 68 (12) : 1455 - 1461
  • [10] Efficacy and Safety of Ipragliflozin in Japanese Type 2 Diabetic Patients
    Takihata, Masahiro
    Terauchi, Yasuo
    DIABETES, 2015, 64 : A311 - A311
12345